Health
AstraZeneca's Tozorakimab Shows Promising Results for COPD in Phase 3 Trials
By Editor • September 8, 2026 • 1 min read
AstraZeneca's experimental drug tozorakimab reduces COPD flare-ups by 30% in late-stage trials, offering hope for millions of patients.
Read more